Global Targeted Radiotherapy Drug Market Research Report 2026(Status And Outlook)

Buy Now
Share to
Facebook
Twitter
LinkedIn
WhatsApp
Base Year
2026
Forecast Period
2024-2029
Pages
137
Industry
Oncology Drugs
Regions
Global
Updated
February 2026

Report Overview


Report Overview
Targeted radiotherapy is a medical treatment designed to direct radioactive isotopes to specific types of tumor cells or tumor markers, allowing for precise tumor treatment. These drugs offer a promising treatment for some malignant tumors, especially those that are advanced or difficult to surgically remove. As technology develops, treatment effects, as well as patient survival and quality of life after treatment, can be better monitored and evaluated. The development trend of targeted radiotherapy drugs emphasizes precise treatment, personalized treatment and comprehensive treatment methods. This will hopefully provide more effective cancer treatments in the future and improve patient survival and quality of life.

The global Targeted Radiotherapy Drug market size was estimated at USD 6568.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.80% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Targeted Radiotherapy Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Targeted Radiotherapy Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Targeted Radiotherapy Drug market.
Global Targeted Radiotherapy Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Novartis
Bayer
Endocyte
Progenics Pharmaceuticals
Jubilant Radiopharma
Curium
Fermi Energia
Nucleus RadioPharma

Market Segmentation (by Type)
Radioactive Iodine Therapeutic Drugs
Radioactive Antibody Therapeutic Drugs
Others

Market Segmentation (by Application)
General Hospital
Specialty Hospital

Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Targeted Radiotherapy Drug Market
Overview of the regional outlook of the Targeted Radiotherapy Drug Market:

Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Targeted Radiotherapy Drug Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Targeted Radiotherapy Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.



Table of Contents

  • 1 Research Methodology and Statistical Scope
    • 1.1 Market Definition and Statistical Scope of Targeted Radiotherapy Drug
    • 1.2 Key Market Segments
      • 1.2.1 Targeted Radiotherapy Drug Segment by Type
      • 1.2.2 Targeted Radiotherapy Drug Segment by Application
    • 1.3 Methodology & Sources of Information
      • 1.3.1 Research Methodology
      • 1.3.2 Research Process
      • 1.3.3 Market Breakdown and Data Triangulation
      • 1.3.4 Base Year
      • 1.3.5 Report Assumptions & Caveats
  • 2 Targeted Radiotherapy Drug Market Overview
    • 2.1 Global Market Overview
      • 2.1.1 Global Targeted Radiotherapy Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
      • 2.1.2 Global Targeted Radiotherapy Drug Sales Estimates and Forecasts (2020-2035)
    • 2.2 Market Segment Executive Summary
    • 2.3 Global Market Size by Region
  • 3 Targeted Radiotherapy Drug Market Competitive Landscape
    • 3.1 Company Assessment Quadrant
    • 3.2 Global Targeted Radiotherapy Drug Product Life Cycle
    • 3.3 Global Targeted Radiotherapy Drug Sales by Manufacturers (2020-2025)
    • 3.4 Global Targeted Radiotherapy Drug Revenue Market Share by Manufacturers (2020-2025)
    • 3.5 Targeted Radiotherapy Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.6 Global Targeted Radiotherapy Drug Average Price by Manufacturers (2020-2025)
    • 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
    • 3.8 Targeted Radiotherapy Drug Market Competitive Situation and Trends
      • 3.8.1 Targeted Radiotherapy Drug Market Concentration Rate
      • 3.8.2 Global 5 and 10 Largest Targeted Radiotherapy Drug Players Market Share by Revenue
      • 3.8.3 Mergers & Acquisitions, Expansion
  • 4 Targeted Radiotherapy Drug Industry Chain Analysis
    • 4.1 Targeted Radiotherapy Drug Industry Chain Analysis
    • 4.2 Market Overview of Key Raw Materials
    • 4.3 Midstream Market Analysis
    • 4.4 Downstream Customer Analysis
  • 5 The Development and Dynamics of Targeted Radiotherapy Drug Market
    • 5.1 Key Development Trends
    • 5.2 Driving Factors
    • 5.3 Market Challenges
    • 5.4 Industry News
      • 5.4.1 New Product Developments
      • 5.4.2 Mergers & Acquisitions
      • 5.4.3 Expansions
      • 5.4.4 Collaboration/Supply Contracts
    • 5.5 PEST Analysis
      • 5.5.1 Industry Policies Analysis
      • 5.5.2 Economic Environment Analysis
      • 5.5.3 Social Environment Analysis
      • 5.5.4 Technological Environment Analysis
    • 5.6 Global Targeted Radiotherapy Drug Market Porters Five Forces Analysis
      • 5.6.1 Global Trade Frictions
      • 5.6.2 U.S. Tariff Policy ? April 2025
      • 5.6.3 Global Trade Frictions and Their Impacts to Targeted Radiotherapy Drug Market
    • 5.7 ESG Ratings of Leading Companies
  • 6 Targeted Radiotherapy Drug Market Segmentation by Type
    • 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
    • 6.2 Global Targeted Radiotherapy Drug Sales Market Share by Type (2020-2025)
    • 6.3 Global Targeted Radiotherapy Drug Market Size by Type (2020-2025)
    • 6.4 Global Targeted Radiotherapy Drug Price by Type (2020-2025)
  • 7 Targeted Radiotherapy Drug Market Segmentation by Application
    • 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
    • 7.2 Global Targeted Radiotherapy Drug Market Sales by Application (2020-2025)
    • 7.3 Global Targeted Radiotherapy Drug Market Size (M USD) by Application (2020-2025)
    • 7.4 Global Targeted Radiotherapy Drug Sales Growth Rate by Application (2020-2025)
  • 8 Targeted Radiotherapy Drug Market Sales by Region
    • 8.1 Global Targeted Radiotherapy Drug Sales by Region
      • 8.1.1 Global Targeted Radiotherapy Drug Sales by Region
      • 8.1.2 Global Targeted Radiotherapy Drug Sales Market Share by Region
    • 8.2 Global Targeted Radiotherapy Drug Market Size by Region
      • 8.2.1 Global Targeted Radiotherapy Drug Market Size by Region
      • 8.2.2 Global Targeted Radiotherapy Drug Market Size by Region
    • 8.3 North America
      • 8.3.1 North America Targeted Radiotherapy Drug Sales by Country
      • 8.3.2 North America Targeted Radiotherapy Drug Market Size by Country
      • 8.3.3 U.S. Market Overview
      • 8.3.4 Canada Market Overview
      • 8.3.5 Mexico Market Overview
    • 8.4 Europe
      • 8.4.1 Europe Targeted Radiotherapy Drug Sales by Country
      • 8.4.2 Europe Targeted Radiotherapy Drug Market Size by Country
      • 8.4.3 Germany Market Overview
      • 8.4.4 France Market Overview
      • 8.4.5 U.K. Market Overview
      • 8.4.6 Italy Market Overview
      • 8.4.7 Spain Market Overview
    • 8.5 Asia Pacific
      • 8.5.1 Asia Pacific Targeted Radiotherapy Drug Sales by Region
      • 8.5.2 Asia Pacific Targeted Radiotherapy Drug Market Size by Region
      • 8.5.3 China Market Overview
      • 8.5.4 Japan Market Overview
      • 8.5.5 South Korea Market Overview
      • 8.5.6 India Market Overview
      • 8.5.7 Southeast Asia Market Overview
    • 8.6 South America
      • 8.6.1 South America Targeted Radiotherapy Drug Sales by Country
      • 8.6.2 South America Targeted Radiotherapy Drug Market Size by Country
      • 8.6.3 Brazil Market Overview
      • 8.6.4 Argentina Market Overview
      • 8.6.5 Columbia Market Overview
    • 8.7 Middle East and Africa
      • 8.7.1 Middle East and Africa Targeted Radiotherapy Drug Sales by Region
      • 8.7.2 Middle East and Africa Targeted Radiotherapy Drug Market Size by Region
      • 8.7.3 Saudi Arabia Market Overview
      • 8.7.4 UAE Market Overview
      • 8.7.5 Egypt Market Overview
      • 8.7.6 Nigeria Market Overview
      • 8.7.7 South Africa Market Overview
  • 9 Targeted Radiotherapy Drug Market Production by Region
    • 9.1 Global Production of Targeted Radiotherapy Drug by Region(2020-2025)
    • 9.2 Global Targeted Radiotherapy Drug Revenue Market Share by Region (2020-2025)
    • 9.3 Global Targeted Radiotherapy Drug Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.4 North America Targeted Radiotherapy Drug Production
      • 9.4.1 North America Targeted Radiotherapy Drug Production Growth Rate (2020-2025)
      • 9.4.2 North America Targeted Radiotherapy Drug Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.5 Europe Targeted Radiotherapy Drug Production
      • 9.5.1 Europe Targeted Radiotherapy Drug Production Growth Rate (2020-2025)
      • 9.5.2 Europe Targeted Radiotherapy Drug Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.6 Japan Targeted Radiotherapy Drug Production (2020-2025)
      • 9.6.1 Japan Targeted Radiotherapy Drug Production Growth Rate (2020-2025)
      • 9.6.2 Japan Targeted Radiotherapy Drug Production, Revenue, Price and Gross Margin (2020-2025)
    • 9.7 China Targeted Radiotherapy Drug Production (2020-2025)
      • 9.7.1 China Targeted Radiotherapy Drug Production Growth Rate (2020-2025)
      • 9.7.2 China Targeted Radiotherapy Drug Production, Revenue, Price and Gross Margin (2020-2025)
  • 10 Key Companies Profile
    • 10.1 Novartis
      • 10.1.1 Novartis Basic Information
      • 10.1.2 Novartis Targeted Radiotherapy Drug Product Overview
      • 10.1.3 Novartis Targeted Radiotherapy Drug Product Market Performance
      • 10.1.4 Novartis Business Overview
      • 10.1.5 Novartis SWOT Analysis
      • 10.1.6 Novartis Recent Developments
    • 10.2 Bayer
      • 10.2.1 Bayer Basic Information
      • 10.2.2 Bayer Targeted Radiotherapy Drug Product Overview
      • 10.2.3 Bayer Targeted Radiotherapy Drug Product Market Performance
      • 10.2.4 Bayer Business Overview
      • 10.2.5 Bayer SWOT Analysis
      • 10.2.6 Bayer Recent Developments
    • 10.3 Endocyte
      • 10.3.1 Endocyte Basic Information
      • 10.3.2 Endocyte Targeted Radiotherapy Drug Product Overview
      • 10.3.3 Endocyte Targeted Radiotherapy Drug Product Market Performance
      • 10.3.4 Endocyte Business Overview
      • 10.3.5 Endocyte SWOT Analysis
      • 10.3.6 Endocyte Recent Developments
    • 10.4 Progenics Pharmaceuticals
      • 10.4.1 Progenics Pharmaceuticals Basic Information
      • 10.4.2 Progenics Pharmaceuticals Targeted Radiotherapy Drug Product Overview
      • 10.4.3 Progenics Pharmaceuticals Targeted Radiotherapy Drug Product Market Performance
      • 10.4.4 Progenics Pharmaceuticals Business Overview
      • 10.4.5 Progenics Pharmaceuticals Recent Developments
    • 10.5 Jubilant Radiopharma
      • 10.5.1 Jubilant Radiopharma Basic Information
      • 10.5.2 Jubilant Radiopharma Targeted Radiotherapy Drug Product Overview
      • 10.5.3 Jubilant Radiopharma Targeted Radiotherapy Drug Product Market Performance
      • 10.5.4 Jubilant Radiopharma Business Overview
      • 10.5.5 Jubilant Radiopharma Recent Developments
    • 10.6 Curium
      • 10.6.1 Curium Basic Information
      • 10.6.2 Curium Targeted Radiotherapy Drug Product Overview
      • 10.6.3 Curium Targeted Radiotherapy Drug Product Market Performance
      • 10.6.4 Curium Business Overview
      • 10.6.5 Curium Recent Developments
    • 10.7 Fermi Energia
      • 10.7.1 Fermi Energia Basic Information
      • 10.7.2 Fermi Energia Targeted Radiotherapy Drug Product Overview
      • 10.7.3 Fermi Energia Targeted Radiotherapy Drug Product Market Performance
      • 10.7.4 Fermi Energia Business Overview
      • 10.7.5 Fermi Energia Recent Developments
    • 10.8 Nucleus RadioPharma
      • 10.8.1 Nucleus RadioPharma Basic Information
      • 10.8.2 Nucleus RadioPharma Targeted Radiotherapy Drug Product Overview
      • 10.8.3 Nucleus RadioPharma Targeted Radiotherapy Drug Product Market Performance
      • 10.8.4 Nucleus RadioPharma Business Overview
      • 10.8.5 Nucleus RadioPharma Recent Developments
  • 11 Targeted Radiotherapy Drug Market Forecast by Region
    • 11.1 Global Targeted Radiotherapy Drug Market Size Forecast
    • 11.2 Global Targeted Radiotherapy Drug Market Forecast by Region
      • 11.2.1 North America Market Size Forecast by Country
      • 11.2.2 Europe Targeted Radiotherapy Drug Market Size Forecast by Country
      • 11.2.3 Asia Pacific Targeted Radiotherapy Drug Market Size Forecast by Region
      • 11.2.4 South America Targeted Radiotherapy Drug Market Size Forecast by Country
      • 11.2.5 Middle East and Africa Forecasted Sales of Targeted Radiotherapy Drug by Country
  • 12 Forecast Market by Type and by Application (2026-2035)
    • 12.1 Global Targeted Radiotherapy Drug Market Forecast by Type (2026-2035)
      • 12.1.1 Global Forecasted Sales of Targeted Radiotherapy Drug by Type (2026-2035)
      • 12.1.2 Global Targeted Radiotherapy Drug Market Size Forecast by Type (2026-2035)
      • 12.1.3 Global Forecasted Price of Targeted Radiotherapy Drug by Type (2026-2035)
    • 12.2 Global Targeted Radiotherapy Drug Market Forecast by Application (2026-2035)
      • 12.2.1 Global Targeted Radiotherapy Drug Sales (K MT) Forecast by Application
      • 12.2.2 Global Targeted Radiotherapy Drug Market Size (M USD) Forecast by Application (2026-2035)
  • 13 Conclusion and Key Findings

Frequently Asked Questions

JSB Market Research is a global provider of market research reports, industry insights, and business intelligence solutions. We help companies, analysts, and decision-makers gain a deeper understanding of global and regional markets.

Our reports deliver data-driven insights, market opportunities, competitive landscapes, and future forecasts. These help your business make informed decisions, enter new markets confidently, and stay ahead of industry trends.

Yes. We offer tailored research services designed to meet your specific market, product, or competitor analysis needs. Our experts work closely with clients to deliver precise, relevant, and actionable insights.

Browse the desired report, select your preferred license type, and complete payment through our secure checkout. For corporate purchases or invoice payments, you can contact our support team directly.

Yes. You can request sample pages or a report overview. This helps you understand the structure, methodology, and depth of analysis before purchasing.